Regencell Bioscience Holdings Limited
NASDAQ:RGC
14.5 (USD) • At close July 18, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||||||||
| Net Income
| -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | -0.002 | -0.002 | -0.002 | -0.002 | -0.002 | -0.002 | -0.001 | -0.001 | -0 | -0 | -0 | -0 | -0 | -0 |
| Depreciation & Amortization
| 0 | 0 | 0 | 0 | 0.77 | 0 | 0 | 0 | 415.597 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.9 | 0 | 0 | 0 | -3.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | 0.001 | 0.001 | 0.001 | -7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 147.7 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 127.3 | 0 | 0 | 0 | 127.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.1 | 0 | 0 | 0 | -1.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -39.9 | 0 | 0 | 0 | -39.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31.6 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 |
| Other Non Cash Items
| 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0.001 | -0 | -0 | -0 | 0 | -0 | -0 |
| Operating Cash Flow
| 0 | 0 | 0 | 0 | 1.539 | 0 | 0 | 0 | -5,427.355 | 0 | 0 | 0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Investing Activities: | ||||||||||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -575.176 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9,634.3 | 0 | 0 | 0 | 160 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10,415.176 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Financing Activities: | ||||||||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -103.6 | 0 | 0 | 0 | -103.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22,483.716 | 0 | 0 | 0 | 103.6 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
| Financing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22,380.116 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
| Other Information: | ||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -408.413 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 0 | 0 | 0 | 0 | 1.539 | 0 | 0 | 0 | 6,188.198 | 0 | 0 | 0 | -228.741 | 0 | -0 | -0 | -0 | -0 | 0 | 0 |
| Cash At End Of Period
| 0 | 0 | 0 | 0 | 1.565 | 0 | 6.417 | 0 | 6,416.998 | 0 | 0 | 0 | 0.059 | 0 | -0 | 0 | 0 | 0.001 | 0.001 | 0 |